Future Oncology
Volume 17, 2021 - Issue 10
Special Report
Pd-L1 Testing Based on The SP142 Antibody in Metastatic Triple-Negative Breast Cancer: Summary of an Expert Round-Table Discussion
Vicente Peg1 Departamento de Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona Hospital Campus, Barcelona, Spain;10 Grupo de Patología Molecular, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain;11 Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain;12 Universitat Autònoma de Barcelona, Bellaterra, Spain
https://orcid.org/0000-0002-5203-6166View further author information
https://orcid.org/0000-0002-5203-6166View further author information, , Laura Comerma3 Departamento de Anatomía Patológica, Hospital del Mar, Barcelona, Spainhttps://orcid.org/0000-0002-0249-4636View further author information
https://orcid.org/0000-0002-0249-4636View further author information, Gloria Peiró4 Departamento de Patología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spainhttps://orcid.org/0000-0002-2899-2908View further author information
https://orcid.org/0000-0002-2899-2908View further author information, Tomás García-Caballero5 Departamento de Ciencias Morfológicas, Facultad de Medicina y Odontología, Universidad de Santiago, Santiago de Compostela, Spainhttps://orcid.org/0000-0002-7938-1437View further author information
https://orcid.org/0000-0002-7938-1437View further author information, , , & Federico Rojo9 Servicio de Anatomía Patológica, IIS-Fundación Jiménez Díaz-CIBERONC, Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0001-9989-0290View further author information
https://orcid.org/0000-0001-9989-0290View further author information show all